| Identification | Back Directory | [Name]
O-2093 | [CAS]
439080-01-0 | [Synonyms]
O-2093
O2093,O 2093
N-(BIS-3-CHLORO-4-HYDROXYBENZYL)-5Z,8Z,11Z,14Z-EICOSATETRAENAMIDE
5,8,11,14-Eicosatetraenamide, N,N-bis[(3-chloro-4-hydroxyphenyl)methyl]-, (5Z,8Z,11Z,14Z)- | [Molecular Formula]
C34H43Cl2NO3 | [MDL Number]
MFCD06798367 | [MOL File]
439080-01-0.mol | [Molecular Weight]
584.62 |
| Chemical Properties | Back Directory | [storage temp. ]
Desiccate at -20°C | [solubility ]
Soluble in ethanol (supplied pre-dissolved in anhydrous ethanol, 5mg/ml) | [form ]
Powder |
| Hazard Information | Back Directory | [Uses]
O-2093 is an inhibitor of anandamide uptake. | [Biological Activity]
Inhibitor of anandamide uptake (IC 50 = 17.3 μ M) with little or no activity at CB 1 , CB 2 , TRPV1 and FAAH. Intravenous administration inhibits limb spasticity in mice with chronic relapsing experimental allergic encephalomyelitis (CREAE). | [in vivo]
O-2093 (1 mg/kg, i.v.) can significantly inhibit limb spasticity in CREATE mice[1].
| [storage]
Desiccate at -20°C |
|
|